Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.80USD
13 Dec 2017
Change (% chg)

$-0.03 (-3.25%)
Prev Close
$0.83
Open
$0.81
Day's High
$0.83
Day's Low
$0.80
Volume
20,852
Avg. Vol
179,321
52-wk High
$5.25
52-wk Low
$0.78

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
FY 2016 Jun '16 0.00 -0.333
Mar '16 0.00 -0.103
Dec 0.00 -0.241
Sep 0.00 -0.153
FY 2015 Jun '15 0.00 -0.031
Mar '15 0.00 -0.214
Dec 0.00 -0.066
Sep 0.00 -0.166
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 3 0.00 0.00 0.00 --
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Jun-17 3 0.00 0.00 0.00 --
Year Ending Jun-18 1 0.00 0.00 0.00 0.00
Year Ending Jun-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-17 3 -0.16 -0.11 -0.22 --
Quarter Ending Mar-18 1 -0.16 -0.16 -0.16 -0.24
Year Ending Jun-17 2 -0.71 -0.65 -0.77 --
Year Ending Jun-18 1 -0.64 -0.64 -0.64 -1.04
Year Ending Jun-19 1 -0.26 -0.26 -0.26 -0.96
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 8.52 20.16
P/E High - Last 5 Yrs. -- 18.64 28.33
P/E Low - Last 5 Yrs. -- 4.63 11.60
Beta 0.80 1.09 1.47
Price to Sales (TTM) -- 8.02 5.92
Price to Book (MRQ) -- 18.36 2.78
Price to Tangible Book (MRQ) 15.80 20.95 2.91
Price to Cash Flow (TTM) -- 3.80 25.65
% Owned Institutions 8.07 0.44 0.68

Dividends

  Company industry sector
Dividend Yield -- 2.51 1.98
Dividend Yield - 5 Year Avg -- 3.30 2.07
Dividend 5 Year Growth Rate -- 7.29 21.91
Payout Ratio(TTM) -- 19.54 18.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 35.04 16.22
Sales (TTM) vs TTM 1 Yr. Ago -- 24.78 11.38
Sales - 5 Yr. Growth Rate -- 24.42 14.11
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.41 134.24 36.73
EPS (TTM) vs TTM 1 Yr. Ago -61.36 -- --
EPS - 5 Yr. Growth Rate -- -3.13 10.47
Capital Spending - 5 Yr. Growth Rate -- 32.97 19.51

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.22 0.05
Current Ratio (MRQ) 2.27 21.81 2.03
LT Debt to Equity (MRQ) 0.00 34.49 31.22
Total Debt to Equity (MRQ) 0.00 39.81 70.72
Interest Coverage (TTM) -16.16 12.51 8.91

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 45.34 3.46
Gross Margin - 5 Yr. Avg. -- 45.09 3.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 37.96 48.24
Operating Margin (TTM) -- 194.45 36.14
Operating Margin - 5 Yr. Avg. -- 95.06 40.78
Pre-Tax Margin (TTM) -- 194.65 36.45
Pre-Tax Margin - 5 Yr. Avg. -- 92.58 41.00
Net Profit Margin (TTM) -- 193.47 29.11
Net Profit Margin - 5 Yr. Avg. -- 91.77 32.36
Effective Tax Rate (TTM) -- 3.67 21.06
Effective Tax Rate - 5 Yr. Avg. -- 2.88 20.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 101,812,208 59,768,643
Net Income/Employee (TTM) -2,234,290 123,972,406 19,592,669
Receivable Turnover (TTM) -- 16.88 8,572.65
Inventory Turnover (TTM) -- 5.29 0.96
Asset Turnover (TTM) 0.00 0.19 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -511.25 11.94 2.59
Return on Assets - 5 Yr. Avg. -- 5.05 2.84
Return on Investment (TTM) -992.44 16.37 0.47
Return on Investment - 5 Yr. Avg. -- 8.62 0.50
Return on Equity (TTM) -- 19.48 15.39
Return on Equity - 5 Yr. Avg. -- 8.22 19.98
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -77.23 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.87%
# of Holders: 9
Total Shares Held: 3,644,212
3 Mo. Net Change: 1,906,037
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 1
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.